Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-01-10
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of LTP-like Pain Amplification in Chronic Low Back Pain Patients
NCT03362827
Interoceptive Exposure as a Treatment Option for Disabling Fear of Pain
NCT03523637
The Test of Those Managing Pain With Their Own Pain
NCT06939543
Effectiveness of a Pain Management Programme
NCT03152604
Do Emotions and Pain Combined Affect Mechanical Pain Thresholds and Other Pain-related Variables
NCT06840743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxytocin group
male participants with oxytocin treatment
oxytocin treatment
intranasal administration of oxytocin
placebo group
male participants with placebo treatment
placebo treatment
intranasal administration of placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin treatment
intranasal administration of oxytocin
placebo treatment
intranasal administration of placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* medical or psychiatric illness
* smoking or drinking 24 hours before experiment
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Kendrick, Dr.
Role: PRINCIPAL_INVESTIGATOR
School of Life Science and Technology, University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.